222

GL PHARM TECH CORP.

No trades
See on Supercharts

204840 fundamentals

An in-depth look to GL PHARM TECH CORP. operating, investing, and financing activities

204840 free cash flow for Q2 24 is -1.57 B KRW. For 2023, 204840 free cash flow was -4.34 B KRW and operating cash flow was -3.76 B KRW.

Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
‪0.00‬
Cash from operating activities
Cash from investing activities
Cash from financing activities
Currency: KRW
Q4 '22
Q1 '23
Q2 '23
Q3 '23
Q4 '23
Q1 '24
Q2 '24
TTM
Free cash flowYoY growth